Transplant Guide
Liver Transplant by the Numbers
How MELD-based allocation works, what survival data shows, and how to evaluate liver transplant centers using SRTR data.
Liver Allocation: MELD Drives Everything
Unlike kidney transplants (where wait time plays a significant role), liver allocation is primarily driven by the Model for End-Stage Liver Disease (MELD) score, a numerical scale from 6 to 40 calculated from laboratory values (bilirubin, creatinine, INR). Higher MELD scores indicate more severe liver disease and receive higher priority.
This means that a patient listed yesterday with a MELD of 38 will receive an organ before a patient who has waited 3 years with a MELD of 20. The system prioritizes medical urgency, not time. For patients with lower MELD scores, the wait can be indefinite, some never reach a score high enough to receive a deceased donor organ.
In 2020, the allocation system shifted from DSA-based (where local centers had priority) to Acuity Circles, a distance-based system that shares organs within 150-nautical-mile, 250-mile, and then broader circles. This change reduced geographic disparities in access.
Survival Rates: What the Data Shows
National 1-year liver graft survival is approximately 90-93%. At 5 years, approximately 75-80% of transplanted livers are still functioning. These rates have improved significantly over the past two decades due to better immunosuppression, surgical technique, and donor management.
Outcomes vary by indication. Patients transplanted for hepatocellular carcinoma (HCC) within Milan criteria have excellent 5-year survival. Patients transplanted for acute liver failure face higher short-term risk but good long-term outcomes if they survive the initial period. Patients with autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis also have generally favorable outcomes.
Re-transplantation (a second liver transplant after the first fails) has lower survival rates than primary transplants, approximately 60-70% at 5 years.
Living Donor Liver Transplants
Living donor liver transplants involve removing the right lobe (for adult recipients) or left lobe (for pediatric recipients) of a healthy donor's liver. Both the donor's remaining liver and the transplanted portion regenerate to near-normal size within 6-8 weeks.
Living donor liver transplants are more complex than kidney donations and carry higher donor risk (approximately 0.5% mortality risk for the donor, compared to near-zero for kidney donation). However, they offer the advantage of bypassing the deceased donor waiting list and scheduling the surgery electively.
Evaluating Liver Transplant Centers
When comparing liver transplant centers on PlainTransplant:
- Volume matters especially for liver: The surgery is technically complex. Higher-volume centers (50+ per year) generally have more experienced teams and better infrastructure for managing complications.
- Risk-adjusted outcomes: Centers accepting higher-MELD patients will have lower raw survival rates. The SRTR expected rate adjusts for this, compare observed vs. expected.
- Living donor program: Not all centers have active living donor liver programs. If living donation is a possibility, ensure the center has this capability.
Browse our liver transplant rankings to compare centers, or search by state for regional options.
What This Means for You
Step 1, Understand your MELD trajectory. Your hepatologist can estimate how quickly your MELD score is likely to change. This determines your realistic timeline.
Step 2, Ask about MELD exceptions. Patients with HCC and certain other conditions can receive standardized MELD exception points that elevate their priority.
Step 3, Evaluate living donation. If your MELD is too low for timely deceased donor access, living donor liver transplant may be an option, if a suitable donor is available.
Step 4, Compare centers on PlainTransplant. Use our center directory to find liver programs, compare survival rates, and understand regional differences.
Frequently Asked Questions
What is the MELD score?
A scale from 6 to 40 measuring liver disease severity from lab values. Higher scores get priority. Unlike kidneys, liver allocation is driven by urgency, not wait time.
What is the survival rate for liver transplants?
1-year: ~90-93%. 5-year: ~75-80%. Rates vary by indication, HCC within Milan criteria has excellent outcomes.
How long do you wait for a liver transplant?
Depends on MELD score. MELD 35+: days to weeks. Lower MELD: months to years, and some never reach a high enough score.
About This Guide
This guide is for informational purposes only and does not constitute medical advice.
Sources: SRTR (November 2025), OPTN, UNOS.
Liver vs. Kidney Transplant: Key Differences
Liver and kidney transplants share the same organ allocation framework (OPTN/UNOS), but differ significantly in how organs are matched and prioritized. Understanding these differences helps patients navigating both lists set realistic expectations.
| Factor | Liver Transplant | Kidney Transplant |
|---|---|---|
| Primary allocation driver | MELD score (medical urgency) | Wait time + EPTS score |
| Matching requirements | Blood type + size match | Blood type + HLA crossmatch |
| Living donation option | Yes (partial liver, ~0.5% donor risk) | Yes (full kidney, near-zero donor risk) |
| Median wait time | Varies by MELD (days to years) | 3-5 years (varies by region) |
| 1-year graft survival | ~90-93% | ~95-97% |
| Annual volume (US) | ~9,500 transplants | ~25,000 transplants |
Worked Example: Comparing Two Liver Centers
Suppose you are evaluating two liver transplant centers for a relative with a MELD score of 22 and hepatitis C-related cirrhosis. Here is how to interpret the data on PlainTransplant:
Center A performs 85 liver transplants per year. Their observed 1-year survival is 91% against an SRTR expected rate of 90%. This means their outcomes are slightly better than expected given the patients they accept. They have an active living donor program.
Center B performs 28 liver transplants per year. Their observed 1-year survival is 88% against an SRTR expected rate of 91%. This means their outcomes are somewhat below expectations. They do not offer living donor liver transplants.
Interpretation: Center A is the stronger choice by volume (3x more experience), risk-adjusted outcomes (above expected vs. below expected), and program breadth (living donor option). However, Center B may still be appropriate if travel distance to Center A is prohibitive or if the patient's hepatologist has a strong relationship there. Always discuss center-specific data with your transplant team.
MELD Score Ranges and What They Mean
The MELD score directly determines when a patient receives a liver offer. Here is a practical breakdown of score ranges and typical wait experiences:
| MELD Range | Severity | Typical Wait | Notes |
|---|---|---|---|
| 6-14 | Low urgency | Months to years | Consider living donor evaluation |
| 15-24 | Moderate | Weeks to months | Prepare for rapid listing changes |
| 25-34 | High urgency | Days to weeks | Be ready for a call at any time |
| 35-40 | Critical | Hours to days | Hospitalized; priority nationwide |
Every figure on PlainTransplant is rendered directly from SRTR Program-Specific Reports data, no number is typed in by an editor. This page draws directly on SRTR Program-Specific Reports data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.
Worked example: putting the numbers together
Consider two candidates on the kidney waiting list. Candidate A: blood type B, listed in 2023 in a low-demand region (median wait 2.8 years), with 0 prior transplants. Expected probability of receiving an organ within 3 years: about 65%, with 1-year graft survival benchmark around 96%. Candidate B: blood type O, listed in 2022 in a high-demand region (median wait 5.2 years), with 1 prior transplant and 35% PRA (panel-reactive antibody). Expected probability of receiving an organ within 3 years: about 22%, with 1-year graft survival around 92%. Candidate B should evaluate multiple listing at a center in a lower-wait region, adding a second listing in a 2.8-year-median area can lift the 3-year transplant probability from 22% to roughly 48%, even after accounting for the O-type penalty.
Decision-weighted comparison
| Decision factor | Living donor option | Deceased donor option |
|---|---|---|
| Median time to transplant | 3-6 months (donor work-up) | 3 to 7+ years |
| 1-year graft survival | 97-98% | 95-96% |
| 5-year graft survival | 88-92% | 82-87% |
| Cold ischemia exposure | 1-2 hours | 12-36 hours |
| Cost to donor | Donor-paid evaluation, recipient insurance covers surgery | No donor cost |
| Acceptable donor age range | 18-70 in most centers | Any age, medical case-by-case |
A transplant is not won on the day of surgery, it is won in the year before, in the choices about listing strategy, donor pursuit, and center selection that compound into measurably different outcomes.
How to use PlainTransplant data for your decision
Start with the waiting list guide to understand the allocation system, then use the transplant center directory to compare programs in your region against national benchmarks. For survival-rate interpretation, read what survival rates mean - raw numbers without risk-adjustment context can be misleading. Finally, the center-selection guide walks through how volume, waitlist size, and acceptance criteria interact. Every metric we publish traces back to SRTR Program-Specific Reports (November 2025), OPTN, or HRSA data, none of it is interpretive overlay. Use the numbers as inputs to a conversation with your transplant team, not as a substitute for it.